Loïc Renaud
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 6
- Chronic Lymphocytic Leukemia Research 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
-
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Xavier Leleu (5 shared papers)Stéphanie Guidez (4 shared papers)Charles Herbaux (3 shared papers)Rossella Cacciola (1 shared paper)Ratko Djukanović (1 shared paper)Riccardo Polosa (1 shared paper)Nunzio Crimi (1 shared paper)G Prosperini (1 shared paper)
- Journals
- Blood (2 papers)Critical Reviews in Oncology/Hematology (1 paper)Clinical Cancer Research (1 paper)Clinical & Translational Immunology (1 paper)HemaSphere (1 paper)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Loïc Renaud
15 papers receiving 226 citations
Peers
Comparison fields: 5 of 44
- Genetics 69
- Hematology 37
- Pathology and Forensic Medicine 54
- Immunology 33
- Oncology 40
Countries citing papers authored by Loïc Renaud
This map shows the geographic impact of Loïc Renaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loïc Renaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loïc Renaud more than expected).
Fields of papers citing papers by Loïc Renaud
This network shows the impact of papers produced by Loïc Renaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loïc Renaud. The network helps show where Loïc Renaud may publish in the future.
Co-authors
The 25 scholars most cited alongside Loïc Renaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 67 | |
| 2 | 2021 | 54 | |
| 3 | 1998 | 29 | |
| 4 | 2019 | 25 | |
| 5 | 2014 | 24 | |
| 6 | 2020 | 7 | |
| 7 | 2016 | 5 | |
| 8 | 2022 | 5 | |
| 9 | 2014 | 4 | |
| 10 | Persistence and possible progression of a pelvic neuroblastoma detected by mass screening during 19 months. | 1994 | 4 |
| 11 | 2021 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2015 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2014 | 1 | |
| 16 | 2026 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2022 | 0 |
About Loïc Renaud
Loïc Renaud is a scholar working on Genetics, Molecular Biology, Pathology and Forensic Medicine, Hematology and Neurology, having authored 18 papers that have together received 229 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Genetics (69 citations), Hematology (37 citations), Pathology and Forensic Medicine (54 citations), Immunology (33 citations) and Oncology (40 citations). Loïc Renaud has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Xavier Leleu, Stéphanie Guidez, Charles Herbaux, Rossella Cacciola, Ratko Djukanović, Riccardo Polosa, Nunzio Crimi, G Prosperini, Catherine Roche‐Lestienne and Christophe Roumier. Their work appears in journals such as Blood, Critical Reviews in Oncology/Hematology, Clinical Cancer Research, Clinical & Translational Immunology and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.